Scientific Program
| Educational Session XI. Updates on Liquid Biopsy | ||
| Crystal 2 + Crystal 3 | ||
|---|---|---|
|
Chair : Young Whan Kim (Seoul National Univ., Korea) Richie Soong (Yong Loo Lin School of Medicine, Singapore) |
||
| Time | Topic | Speaker |
| 11:00-11:30 | The Value Proposition of Liquid Biopsies to Precision Medicine | Richie Soong (Yong Loo Lin School of Medicine, Singapore) |
| 11:30-12:00 | Liquid Biopsy Successfully Detects Best Drugs for Treating Lung Cancer  |
James Yang (National Taiwan University Hospital, Taiwan) |
| 12:00-12:30 | Extracellular Vesicles(EV)-derived DNA for Liquid Biopsy in Lung Cancer | Kye Young Lee (Konkuk Univ., Korea) |
| Educational Session XII. New Staging | ||
| Crystal 3 | ||
|---|---|---|
|
Chair : Geon Kook Lee (National Cancer Center, Korea) Shiu-Feng Huang (Institute of Molecular and Genomic Medicine, Taiwan) |
||
| Time | Topic | Speaker |
| 11:00-11:30 | The Clinical Correlation of the 8th AJCC Staging System in Lung Adenocarcinoma Focusing on Early Stage Patients: Taiwan Experience |
Shiu-Feng Huang (Institute of Molecular and Genomic Medicine, Taiwan) |
| 11:30-12:00 | Lung Cancers with Multiple Pulmonary Sites of Involvement in the Eighth Edition of the TNM Classification |
Hyo Sup Shim (Yonsei Univ., Korea) |
| 12:00-12:30 | Clinical Significance of New WHO Classification of Lung Cancer |
Hironori Ninomiya (The Cancer Institute Hospital of Japanese Foundation For Cancer Research, Japan) |
| Educational Session XIII. Lung Cancer Screening | ||
| Emerald | ||
|---|---|---|
|
Chair : Jin Mo Goo (Seoul National Univ., Korea) Matthijs Oudkerk(NELSON, Netherlands) |
||
| Time | Topic | Speaker |
| 11:00-11:30 | Korean Lung Cancer Screening Project: Initial Results | Hyae Young Kim (National Cancer Center, Korea) |
| 11:30-12:00 | Lung Cancer Screening: European Experience | Matthijs Oudkerk(NELSON, Netherlands) |
| 12:00-12:30 | Question and Answer | |
| Industry-Sponsored Symposium V. [Boehringer Ingelheim] | ||
| Crystal 1 | ||
|---|---|---|
| Chair : Taewon Jang (Kosin Univ., Korea) | ||
| Time | Topic | Speaker |
| 07:50-08:30 | Optimal Treatment Sequence in EGFR Targeted Therapy with Long Term Perspective |
Maximilian J. Hochmair (Otto Wagner Hospital, Vienna, Austria) |
| Industry-Sponsored Symposium VI. [Novartis] | ||
| Crystal 2 | ||
|---|---|---|
| Chair : Jin Seok Ahn (Sungkyunkwan Univ., Korea) | ||
| Time | Topic | Speaker |
| 07:50-08:30 | New Target Agent: Dabrafenib Plus Trametinib in Patients with BRAF Mutant Metastatic Non-Small Cell Lung Cancer |
James Chung-man Ho (The University of Hong Kong, Hong Kong) |
| Industry-Sponsored Symposium VII. [Roche] | ||
| Crystal 3 | ||
|---|---|---|
| Chair : Jeong Seon Ryu (Inha Univ., Korea) | ||
| Time | Topic | Speaker |
| 07:50-08:30 | The evolving power of immunotherapy :
Tecentriq in Advanced Lung cancer |
Takashi Seto (National Kyushu Cancer Center) |
| Plenary Session II. Predictive Marker for Immunotherapy Basic Perspective for Immunotherapy in Lung Cancer | ||
| Crystal 1 + Crystal 2 + Crystal 3 | ||
|---|---|---|
|
Chair : Myung Ju Ahn (Sungkyunkwan Univ., Korea) Michael Boyer(Chris O'Brien Lifehouse, Australia) |
||
| Time | Topic | Speaker |
| 09:00-09:30 | Basic Perspective for Immunotherapy in Lung Cancer | Eui Cheol Shin (KAIST, Korea) |
| 09:30-10:00 | Clinical Perspective for Current Immunotherapy in NSCLC |
Michael Boyer (Chris O'Brien Lifehouse, Australia) |
| 10:00-10:30 | Beyond PD-l/PD-L1 Inhibitor: New Targeted Immunotherapy or Combination Therapy |
Tien Hoang (Genentech, USA) |